These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17454579)

  • 1. Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
    Quintás-Cardama A; Verstovsek S
    Leuk Lymphoma; 2007 Mar; 48(3):445-6. PubMed ID: 17454579
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
    Al Bahar S; Pandita R; Nath SV
    Int J Gynaecol Obstet; 2004 Jun; 85(3):281-2. PubMed ID: 15145269
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL; Granados E; Peñarrubia MJ
    Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
    [No Abstract]   [Full Text] [Related]  

  • 4. Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
    Agarwal BR; Gulvady A; Joshi K; Khemani S; Currimbhoy ZE
    Indian Pediatr; 1995 Sep; 32(9):1002-4. PubMed ID: 8935266
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case report of sustained virological response with PEG-interferon-α-2b in a patient with CML and hepatitis C prior fail in ten-year treatment of conventional interferon].
    Luo WF; Peng J
    Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):783-4. PubMed ID: 24579216
    [No Abstract]   [Full Text] [Related]  

  • 6. The interferon-alpha revival in CML.
    Talpaz M; Mercer J; Hehlmann R
    Ann Hematol; 2015 Apr; 94 Suppl 2():S195-207. PubMed ID: 25814086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
    Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
    N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of chronic myelogenous leukemia.
    Talpaz M; Kantarjian H; McCredie K; Trujillo J; Keating M; Gutterman JU
    Cancer; 1987 Feb; 59(3 Suppl):664-7. PubMed ID: 10822467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
    Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
    Müller-Tidow C; Kiehl M; Sindermann JR; Probst M; Banger N; Zühlsdorf M; Chou TC; Berdel WE; Serve H; Koch OM
    Int J Oncol; 2003 Jul; 23(1):151-8. PubMed ID: 12792788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia.
    Lipton JH; Khoroshko N; Golenkov A; Abdulkadyrov K; Nair K; Raghunadharao D; Brummendorf T; Yoo K; Bergstrom B;
    Leuk Lymphoma; 2007 Mar; 48(3):497-505. PubMed ID: 17454589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Nau JY
    Rev Med Suisse; 2017 Feb; 13(549):386-387. PubMed ID: 28708364
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia.
    Messori A; Becagli P; Trippoli S
    Ann Intern Med; 1997 Apr; 126(8):664-5. PubMed ID: 9103145
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.
    Guilhot F; Lacotte-Thierry L
    Hematol Cell Ther; 1998 Oct; 40(5):237-9. PubMed ID: 9844819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
    Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?
    Goldman J
    Nat Clin Pract Oncol; 2005 Mar; 2(3):126-7. PubMed ID: 16264901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.